Trademarkia Logo

United Kingdom

£
Trademark Search
RYBLOZEL

View On IPO.GOV.UK

Registered

on 29 Jun 2017

Last Applicant/ Owned by

Celgene Corporation

86 Morris Avenue, Summit, New Jersey 07901, United States of America

, ,

Serial Number

UK00003240557 filed on 29th Jun 2017

Registration Number

UK00003240557 registered on
22nd Sept 2017

Correspondent Information

Sipara Limited

Rochester House, Eynsham Road, Farmoor

Oxford,

OX2 9NH

RYBLOZEL

pharmaceutical preparations for use in the treatment of beta thalassemia and myelodsplatic syndromes, autoinflammatory disease, autoimmune disease, bl Read More

Classification Information

Class [5]
Pharmaceutical Products

Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodsplatic syndromes, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system.

Mark Details

Serial Number

UK00003240557

Mark Type

Word

Kind of mark

Individual